Kangmei Pharmaceutical Co., Ltd.
SHH: 600518.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Guoxiong Ou
- Employees
- 4,409
- Headquarters
- Puning, China
- IPO year
- 2001
- Market cap
- CN¥23.5B
- Website
- https://www.kangmei.com.cn
Loading 600518…
Loading profile data…Frequently asked questions about 600518
What does Kangmei Pharmaceutical Co., Ltd. (600518.SS) do?
Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese medicines in China. It also offers chemical drug products; and operates hospitals and Chinese medicine pharmacies. The company was founded in 1997 and is headquartered in Puning, China.
Where does 600518.SS trade?
Kangmei Pharmaceutical Co., Ltd. (600518.SS) trades on the Shanghai Stock Exchange.
What sector is 600518.SS in?
Kangmei Pharmaceutical Co., Ltd. (600518.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Kangmei Pharmaceutical Co., Ltd.?
Guoxiong Ou is the chief executive officer of Kangmei Pharmaceutical Co., Ltd. (600518.SS).
Where is Kangmei Pharmaceutical Co., Ltd. headquartered?
Kangmei Pharmaceutical Co., Ltd. is headquartered in China.
Does 600518.SS pay a dividend?
Kangmei Pharmaceutical Co., Ltd. (600518.SS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 600518.SS go public?
Kangmei Pharmaceutical Co., Ltd. (600518.SS) completed its initial public offering in 2001.